I: Chapter 2. Controlling Occupational Exposure to Hazardous Drugs. OSHA, 1999.
http://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html
NIH [2002]. 1999 recommendations for the safe handling of cytotoxic drugs. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, NIH Publication No. 92-2621.
American Society of Health-System Pharmacists. (2006) ASHP Guidelines on Handling Hazardous Drugs.
Polovich, M., White, J. M., & Kelleher, L. O. (eds.) 2005. Chemotherapy and biotherapy guidelines and recommendations for practice (2nd. ed.) Pittsburgh, PA: Oncology Nursing Society.
Literature revised May 7, 2007
Eli Lilly and Company
Indianapolis, IN 46285, USA
Copyright © 1996, 2007, Eli Lilly and Company. All rights reserved.
Gemzar (Gemcitabine hydrochloride)
PRODUCT INFO
Product Code 0002-7501 Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration INTRAVENOUS DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Gemcitabine hydrochloride (Gemcitabine) Active 200 MILLIGRAM In 5 MILLILITER
Mannitol Inactive 200 MILLIGRAM In 5 MILLILITER
Sodium acetate Inactive 12.5 MILLIGRAM In 5 MILLILITER
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0002-7501-01 5 MILLILITER In 1 VIAL None
Gemzar (Gemcitabine hydrochloride)
PRODUCT INFO
Product Code 0002-7502 Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration INTRAVENOUS DEA Schedule
INGREDIENTS
Name (Active Moiety) Type Strength
Gemcitabine hydrochloride (Gemcitabine) Active 1 GRAM In 25 MILLILITER
Mannitol Inactive 1 GRAM In 25 MILLILITER
Sodium acetate Inactive 62.5 MILLIGRAM In 25 MILLILITER
IMPRINT INFORMATION
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
Size
PACKAGING
# NDC Package Description Multilevel Packaging
1 0002-7502-01 25 MILLILITER In 1 VIAL None
Revised: 07/2008Eli Lilly and Company
